Skip to main content
Erschienen in: Journal of Neurology 3/2010

01.03.2010 | Original Communication

Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis

verfasst von: Linn Hofsøy Steffensen, Svein Ivar Mellgren, Margitta T. Kampman

Erschienen in: Journal of Neurology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

The implications of having multiple sclerosis (MS) for bone health are incompletely understood. The aim of this population-based study is to identify past and current exposures that are associated with bone mass in fully ambulatory persons with MS up to age 50 years and to determine the prevalence of low bone mineral density (BMD) in this group. We measured BMD (hips, lumbar spine, forearms), physical function, BMI, and serum 25(OH) vitamin D in 55 women and 25 men with MS. Patients provided information on demographic variables and medical history, as well as past and current vitamin D and calcium intake, physical activity, and lifestyle habits. In regression analyses, BMD levels were adjusted for age, sex, and BMI. At the femoral neck, strong associations were found for walking distance (beta = 0.152; P < 0.001) and age (beta = −0.004; P = 0.003), and less certain associations for male sex (beta = 0.055; P = 0.014) and 10-foot timed tandem walk (−0.008; P = 0.013). At the lumbar spine, walking distance (beta = 0.013; P = 0.006) and possibly physical activity growing up (beta = 0.035; P = 0.028) and male sex (beta = −0.057; P = 0.042), were associated with BMD. At the ultradistal radius, strength of grip (beta = 0.001; P = 0.002), and, less certainly, summer outdoor activities age 16–20 (beta = 0.021; P = 0.009), and age at MS onset (beta = 0.002; P = 0.036) were associated with BMD. Low BMD (z score ≤−2) was present in 19 out of 80 patients. This study shows that MS-related variables as well as past exposures differentially affect BMD at three clinically important skeletal sites. Low BMD is prevalent in these young patients. Bone health should receive attention in care for persons with MS.
Literatur
1.
Zurück zum Zitat Altintas A, Saruhan-Direskeneli G, Benbir G, Demir M, Purisa S (2008) The role of osteopontin: a shared pathway in the pathogenesis of multiple sclerosis and osteoporosis? J Neurol Sci 276:41–44CrossRefPubMed Altintas A, Saruhan-Direskeneli G, Benbir G, Demir M, Purisa S (2008) The role of osteopontin: a shared pathway in the pathogenesis of multiple sclerosis and osteoporosis? J Neurol Sci 276:41–44CrossRefPubMed
2.
Zurück zum Zitat Aydin G, Atalar E, Keles I, Tosun A, Zog G, Keles H, Orkun S (2006) Predictive value of grip strength for bone mineral density in males: site specific or systemic? Rheumatol Int 27:125–129CrossRefPubMed Aydin G, Atalar E, Keles I, Tosun A, Zog G, Keles H, Orkun S (2006) Predictive value of grip strength for bone mineral density in males: site specific or systemic? Rheumatol Int 27:125–129CrossRefPubMed
3.
Zurück zum Zitat Bainbridge KE, Sowers M, Lin X, Harlow SD (2004) Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women. Osteoporos Int 15:439–446CrossRefPubMed Bainbridge KE, Sowers M, Lin X, Harlow SD (2004) Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women. Osteoporos Int 15:439–446CrossRefPubMed
4.
Zurück zum Zitat Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B (2004) Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116:634–639CrossRefPubMed Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B (2004) Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116:634–639CrossRefPubMed
5.
Zurück zum Zitat Bonnick SL (2004) Bone densitometry in clinical practice. Application and interpretation. Humana Press Inc, Totowa Bonnick SL (2004) Bone densitometry in clinical practice. Application and interpretation. Humana Press Inc, Totowa
6.
Zurück zum Zitat Cosman F, Nieves J, Komar L, Ferrer G, Herbert J, Formica C, Shen V, Lindsay R (1998) Fracture history and bone loss in patients with MS. Neurology 51:1161–1165PubMed Cosman F, Nieves J, Komar L, Ferrer G, Herbert J, Formica C, Shen V, Lindsay R (1998) Fracture history and bone loss in patients with MS. Neurology 51:1161–1165PubMed
7.
Zurück zum Zitat Emaus N, Berntsen GK, Joakimsen RM, Fonnebo V (2005) Longitudinal changes in forearm bone mineral density in women and men aged 25–44 years: the Tromso study: a population-based study. Am J Epidemiol 162:633–643CrossRefPubMed Emaus N, Berntsen GK, Joakimsen RM, Fonnebo V (2005) Longitudinal changes in forearm bone mineral density in women and men aged 25–44 years: the Tromso study: a population-based study. Am J Epidemiol 162:633–643CrossRefPubMed
8.
Zurück zum Zitat Formica CA, Cosman F, Nieves J, Herbert J, Lindsay R (1997) Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid use. Calcif Tissue Int 61:129–133CrossRefPubMed Formica CA, Cosman F, Nieves J, Herbert J, Lindsay R (1997) Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid use. Calcif Tissue Int 61:129–133CrossRefPubMed
10.
Zurück zum Zitat Herbert J, Jakubowska-Sadowska K, Russell HK, Kasten LE, Layer N, Glueck A, Frankel M, Fromm JT, DelBene M (2006) The timed tandem walk is a more informative measure of mild impairment in patients with multiple sclerosis than the 25-foot walk. Mult Scler 12:S87 Abstract Herbert J, Jakubowska-Sadowska K, Russell HK, Kasten LE, Layer N, Glueck A, Frankel M, Fromm JT, DelBene M (2006) The timed tandem walk is a more informative measure of mild impairment in patients with multiple sclerosis than the 25-foot walk. Mult Scler 12:S87 Abstract
11.
Zurück zum Zitat Hjartaker A, Andersen LF, Lund E (2007) Comparison of diet measures from a food-frequency questionnaire with measures from repeated 24-h dietary recalls. The Norwegian Women and Cancer Study. Public Health Nutr 10:1094–1103CrossRefPubMed Hjartaker A, Andersen LF, Lund E (2007) Comparison of diet measures from a food-frequency questionnaire with measures from repeated 24-h dietary recalls. The Norwegian Women and Cancer Study. Public Health Nutr 10:1094–1103CrossRefPubMed
13.
Zurück zum Zitat Hotermans C, Dive D, Rinkin M, Leroy M, Malaise M, Moonen G, Franchimont N (2006) Hip bone mineral density is correlated with EDSS in patients with multiple sclerosis. J Neurol 253:ii126 Abstract Hotermans C, Dive D, Rinkin M, Leroy M, Malaise M, Moonen G, Franchimont N (2006) Hip bone mineral density is correlated with EDSS in patients with multiple sclerosis. J Neurol 253:ii126 Abstract
14.
Zurück zum Zitat Kampman MT, Brustad M (2008) Vitamin D: a candidate for the environmental effect in multiple sclerosis—observations from Norway. Neuroepidemiology 30:140–146CrossRefPubMed Kampman MT, Brustad M (2008) Vitamin D: a candidate for the environmental effect in multiple sclerosis—observations from Norway. Neuroepidemiology 30:140–146CrossRefPubMed
15.
Zurück zum Zitat Kampman MT, Steffensen LH (2009) Comment on Shuhaibar et al.: favourable effect of immunomodulator therapy on bone mineral density in multiple sclerosis. Ir J Med Sci 178:235–236CrossRefPubMed Kampman MT, Steffensen LH (2009) Comment on Shuhaibar et al.: favourable effect of immunomodulator therapy on bone mineral density in multiple sclerosis. Ir J Med Sci 178:235–236CrossRefPubMed
16.
Zurück zum Zitat Kampman MT, Wilsgaard T, Mellgren SI (2007) Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 254:471–477CrossRefPubMed Kampman MT, Wilsgaard T, Mellgren SI (2007) Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 254:471–477CrossRefPubMed
17.
Zurück zum Zitat Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMed Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452PubMed
18.
19.
Zurück zum Zitat McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den NS, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127CrossRefPubMed McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den NS, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127CrossRefPubMed
20.
Zurück zum Zitat Michels KB, Willett WC, Graubard BI, Vaidya RL, Cantwell MM, Sansbury LB, Forman MR (2007) A longitudinal study of infant feeding and obesity throughout life course. Int J Obes (Lond) 31:1078–1085CrossRef Michels KB, Willett WC, Graubard BI, Vaidya RL, Cantwell MM, Sansbury LB, Forman MR (2007) A longitudinal study of infant feeding and obesity throughout life course. Int J Obes (Lond) 31:1078–1085CrossRef
21.
Zurück zum Zitat Mojtahedi MC, Snook EM, Motl RW, Evans EM (2008) Bone health in ambulatory individuals with multiple sclerosis: impact of physical activity, glucocorticoid use, and body composition. J Rehabil Res Dev 45:851–861CrossRefPubMed Mojtahedi MC, Snook EM, Motl RW, Evans EM (2008) Bone health in ambulatory individuals with multiple sclerosis: impact of physical activity, glucocorticoid use, and body composition. J Rehabil Res Dev 45:851–861CrossRefPubMed
23.
Zurück zum Zitat Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296:2832–2838CrossRefPubMed Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296:2832–2838CrossRefPubMed
24.
Zurück zum Zitat Nieves J, Cosman F, Herbert J, Shen V, Lindsay R (1994) High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687–1692PubMed Nieves J, Cosman F, Herbert J, Shen V, Lindsay R (1994) High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687–1692PubMed
25.
Zurück zum Zitat Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952CrossRefPubMed Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952CrossRefPubMed
26.
Zurück zum Zitat Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y (2005) Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab 23:309–313CrossRefPubMed Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y (2005) Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab 23:309–313CrossRefPubMed
27.
28.
29.
Zurück zum Zitat Schwid SR, Goodman AD, Puzas JE, McDermott MP, Mattson DH (1996) Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis. Arch Neurol 53:753–757PubMed Schwid SR, Goodman AD, Puzas JE, McDermott MP, Mattson DH (1996) Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis. Arch Neurol 53:753–757PubMed
30.
Zurück zum Zitat Stepan JJ, Havrdova E, Tyblova M, Horakova D, Ticha V, Novakova I, Zikan V (2004) Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids. Clin Chim Acta 348:147–154CrossRefPubMed Stepan JJ, Havrdova E, Tyblova M, Horakova D, Ticha V, Novakova I, Zikan V (2004) Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids. Clin Chim Acta 348:147–154CrossRefPubMed
31.
Zurück zum Zitat Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7:292–304CrossRefPubMed Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7:292–304CrossRefPubMed
32.
Zurück zum Zitat Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM, Blondeau L, Berger C, Hanley DA, Prior JC (2000) Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 11:897–904CrossRefPubMed Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM, Blondeau L, Berger C, Hanley DA, Prior JC (2000) Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 11:897–904CrossRefPubMed
33.
Zurück zum Zitat Tuzun S, Altintas A, Karacan I, Tangurek S, Saip S, Siva A (2003) Bone status in multiple sclerosis: beyond corticosteroids. Mult Scler 9:600–604CrossRefPubMed Tuzun S, Altintas A, Karacan I, Tangurek S, Saip S, Siva A (2003) Bone status in multiple sclerosis: beyond corticosteroids. Mult Scler 9:600–604CrossRefPubMed
34.
Zurück zum Zitat Vainionpaa A, Korpelainen R, Leppaluoto J, Jamsa T (2005) Effects of high-impact exercise on bone mineral density: a randomized controlled trial in premenopausal women. Osteoporos Int 16:191–197CrossRefPubMed Vainionpaa A, Korpelainen R, Leppaluoto J, Jamsa T (2005) Effects of high-impact exercise on bone mineral density: a randomized controlled trial in premenopausal women. Osteoporos Int 16:191–197CrossRefPubMed
35.
Zurück zum Zitat van der Mei IAF, Blizzard L, Ponsonby AL, Dwyer T (2006) Validity and reliability of adult recall of past sun exposure in a case–control study of multiple sclerosis. Cancer Epidemiol Biomarkers Prev 15:1538–1544CrossRefPubMed van der Mei IAF, Blizzard L, Ponsonby AL, Dwyer T (2006) Validity and reliability of adult recall of past sun exposure in a case–control study of multiple sclerosis. Cancer Epidemiol Biomarkers Prev 15:1538–1544CrossRefPubMed
36.
Zurück zum Zitat van der Mei IAF, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ (2007) Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 254:581–590CrossRefPubMed van der Mei IAF, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ (2007) Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 254:581–590CrossRefPubMed
37.
Zurück zum Zitat Vondracek SF, Hansen LB, McDermott MT (2009) Osteoporosis risk in premenopausal women. Pharmacotherapy 29:305–317CrossRefPubMed Vondracek SF, Hansen LB, McDermott MT (2009) Osteoporosis risk in premenopausal women. Pharmacotherapy 29:305–317CrossRefPubMed
38.
Zurück zum Zitat Weinstock-Guttman B, Gallagher E, Baier M, Green L, Feichter J, Patrick K, Miller C, Wrest K, Ramanathan M (2004) Risk of bone loss in men with multiple sclerosis. Mult Scler 10:170–175CrossRefPubMed Weinstock-Guttman B, Gallagher E, Baier M, Green L, Feichter J, Patrick K, Miller C, Wrest K, Ramanathan M (2004) Risk of bone loss in men with multiple sclerosis. Mult Scler 10:170–175CrossRefPubMed
39.
Zurück zum Zitat Weinstock-Guttman B, Hong J, Santos R, Tamano-Blanco M, Badgett D, Patrick K, Baier M, Feichter J, Gallagher E, Garg N, Ramanathan M (2006) Interferon-beta modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients. Mult Scler 12:541–550CrossRefPubMed Weinstock-Guttman B, Hong J, Santos R, Tamano-Blanco M, Badgett D, Patrick K, Baier M, Feichter J, Gallagher E, Garg N, Ramanathan M (2006) Interferon-beta modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients. Mult Scler 12:541–550CrossRefPubMed
40.
Zurück zum Zitat Writing group for the ISCD position developement conference (2004) Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom 7:17–26CrossRef Writing group for the ISCD position developement conference (2004) Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom 7:17–26CrossRef
41.
Zurück zum Zitat Zorzon M, Zivadinov R, Locatelli L, Giuntini D, Toncic M, Bosco A, Nasuelli D, Bratina A, Tommasi MA, Rudick RA, Cazzato G (2005) Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. Eur J Neurol 12:550–556CrossRefPubMed Zorzon M, Zivadinov R, Locatelli L, Giuntini D, Toncic M, Bosco A, Nasuelli D, Bratina A, Tommasi MA, Rudick RA, Cazzato G (2005) Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. Eur J Neurol 12:550–556CrossRefPubMed
Metadaten
Titel
Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis
verfasst von
Linn Hofsøy Steffensen
Svein Ivar Mellgren
Margitta T. Kampman
Publikationsdatum
01.03.2010
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 3/2010
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5337-6

Weitere Artikel der Ausgabe 3/2010

Journal of Neurology 3/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.